End-of-day quote
Korea S.E.
06:00:00 2024-05-02 pm EDT
|
5-day change
|
1st Jan Change
|
317,000
KRW
|
-0.78%
|
|
+2.09%
|
-10.07%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,490,741
|
4,397,245
|
3,373,870
|
3,711,167
|
4,473,421
|
4,022,134
|
-
|
-
|
Enterprise Value (EV)
2 |
4,184
|
5,040
|
3,855
|
4,231
|
4,473
|
4,284
|
4,022
|
3,854
|
P/E ratio
|
65.7
x
|
368
x
|
50.3
x
|
36.5
x
|
30.6
x
|
23.2
x
|
21.1
x
|
18.8
x
|
Yield
|
0.17%
|
0.14%
|
0.18%
|
0.17%
|
-
|
0.16%
|
0.16%
|
0.16%
|
Capitalization / Revenue
|
3.13
x
|
4.09
x
|
2.8
x
|
2.79
x
|
3
x
|
2.47
x
|
2.28
x
|
2.31
x
|
EV / Revenue
|
3.76
x
|
4.68
x
|
3.2
x
|
3.18
x
|
3
x
|
2.63
x
|
2.28
x
|
2.22
x
|
EV / EBITDA
|
26.3
x
|
45.7
x
|
18
x
|
16.6
x
|
14
x
|
12.2
x
|
11
x
|
9.71
x
|
EV / FCF
|
-27.2
x
|
45.9
x
|
21.2
x
|
32.1
x
|
-
|
23.4
x
|
19.8
x
|
18.5
x
|
FCF Yield
|
-3.67%
|
2.18%
|
4.72%
|
3.12%
|
-
|
4.27%
|
5.06%
|
5.39%
|
Price to Book
|
4.73
x
|
6.02
x
|
4.2
x
|
4.26
x
|
-
|
3.66
x
|
3.11
x
|
2.78
x
|
Nbr of stocks (in thousands)
|
12,744
|
12,732
|
12,718
|
12,703
|
12,691
|
12,688
|
-
|
-
|
Reference price
3 |
273,920
|
345,361
|
265,283
|
292,157
|
352,500
|
317,000
|
317,000
|
317,000
|
Announcement Date
|
2/7/20
|
2/4/21
|
1/27/22
|
2/8/23
|
2/2/24
|
-
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,114
|
1,076
|
1,206
|
1,332
|
1,491
|
1,627
|
1,762
|
1,738
|
EBITDA
1 |
159.3
|
110.3
|
214.5
|
254.9
|
319.1
|
349.9
|
366.9
|
397
|
EBIT
1 |
103.9
|
48.68
|
127.4
|
157
|
220.7
|
255.6
|
273.7
|
309.4
|
Operating Margin
|
9.33%
|
4.52%
|
10.56%
|
11.79%
|
14.8%
|
15.71%
|
15.53%
|
17.8%
|
Earnings before Tax (EBT)
1 |
83.3
|
22.13
|
103.8
|
116.9
|
194
|
232.9
|
258.3
|
293.6
|
Net income
1 |
52.11
|
11.96
|
81.08
|
76.93
|
159.3
|
173.4
|
188
|
215.5
|
Net margin
|
4.68%
|
1.11%
|
6.72%
|
5.78%
|
10.68%
|
10.66%
|
10.67%
|
12.4%
|
EPS
2 |
4,170
|
939.5
|
5,270
|
7,994
|
11,522
|
13,675
|
14,998
|
16,877
|
Free Cash Flow
3 |
-153,685
|
109,719
|
181,974
|
131,890
|
-
|
182,715
|
203,458
|
207,838
|
FCF margin
|
-13,800.71%
|
10,198.36%
|
15,088.37%
|
9,903.76%
|
-
|
11,230.84%
|
11,545.15%
|
11,957.93%
|
FCF Conversion (EBITDA)
|
-
|
99,459.77%
|
84,835.58%
|
51,735.49%
|
-
|
52,219.32%
|
55,458.87%
|
52,357.88%
|
FCF Conversion (Net income)
|
-
|
917,443.51%
|
224,446.95%
|
171,451.1%
|
-
|
105,361.15%
|
108,201.97%
|
96,444.32%
|
Dividend per Share
2 |
461.9
|
471.2
|
480.6
|
490.2
|
-
|
495.0
|
500.5
|
500.0
|
Announcement Date
|
2/7/20
|
2/4/21
|
1/27/22
|
2/8/23
|
2/2/24
|
-
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
303.1
|
350.5
|
321.1
|
316.5
|
342.1
|
351.3
|
361.7
|
342.7
|
364.6
|
422.4
|
403.7
|
386.1
|
400.6
|
438.5
|
422.5
|
EBITDA
1 |
-
|
-
|
-
|
54.47
|
72.67
|
64.1
|
84.57
|
57.83
|
-
|
94.72
|
94.8
|
74.1
|
85.6
|
74.3
|
-
|
EBIT
1 |
36.88
|
42.72
|
38.67
|
29.57
|
46.8
|
37.76
|
60.45
|
33.16
|
57.52
|
70.1
|
76.64
|
49.32
|
59.04
|
66.3
|
70.05
|
Operating Margin
|
12.17%
|
12.19%
|
12.04%
|
9.34%
|
13.68%
|
10.75%
|
16.71%
|
9.67%
|
15.78%
|
16.6%
|
18.99%
|
12.77%
|
14.74%
|
15.12%
|
16.58%
|
Earnings before Tax (EBT)
1 |
32.12
|
34.14
|
35.67
|
26.41
|
37.89
|
16.6
|
55.62
|
25.43
|
56.28
|
56.91
|
74.98
|
51.7
|
48.6
|
59.8
|
72.05
|
Net income
1 |
23.4
|
17.47
|
19.31
|
18.02
|
25.37
|
13.61
|
43.11
|
16.06
|
54.71
|
47.45
|
55
|
38.2
|
32
|
41.8
|
37.7
|
Net margin
|
7.72%
|
4.98%
|
6.01%
|
5.69%
|
7.42%
|
3.87%
|
11.92%
|
4.68%
|
15%
|
11.23%
|
13.63%
|
9.89%
|
7.99%
|
9.53%
|
8.92%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/4/21
|
1/27/22
|
4/27/22
|
7/18/22
|
11/1/22
|
2/8/23
|
4/26/23
|
7/28/23
|
11/1/23
|
2/2/24
|
4/30/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
693
|
643
|
481
|
519
|
-
|
262
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
0.53
|
168
|
Leverage (Debt/EBITDA)
|
4.354
x
|
5.825
x
|
2.244
x
|
2.038
x
|
-
|
0.7476
x
|
-
|
-
|
Free Cash Flow
2 |
-153,685
|
109,719
|
181,974
|
131,890
|
-
|
182,715
|
203,458
|
207,838
|
ROE (net income / shareholders' equity)
|
7.93%
|
1.65%
|
9.21%
|
9.89%
|
15.1%
|
17.1%
|
15.4%
|
16.3%
|
ROA (Net income/ Total Assets)
|
3.54%
|
0.63%
|
3.51%
|
4.29%
|
-
|
9.25%
|
9.34%
|
9.67%
|
Assets
1 |
1,471
|
1,898
|
2,310
|
1,794
|
-
|
1,876
|
2,013
|
2,228
|
Book Value Per Share
3 |
57,930
|
57,329
|
63,128
|
68,632
|
-
|
86,697
|
101,768
|
114,138
|
Cash Flow per Share
3 |
996.0
|
11,901
|
15,876
|
12,773
|
-
|
23,787
|
24,665
|
26,197
|
Capex
1 |
166
|
41.8
|
19.9
|
30.4
|
-
|
50.7
|
60.6
|
54.7
|
Capex / Sales
|
14.92%
|
3.89%
|
1.65%
|
2.28%
|
-
|
3.11%
|
3.44%
|
3.15%
|
Announcement Date
|
2/7/20
|
2/4/21
|
1/27/22
|
2/8/23
|
2/2/24
|
-
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Last Close Price
317,000
KRW Average target price
408,986
KRW Spread / Average Target +29.02% Consensus |
1st Jan change
|
Capi.
|
---|
| -10.07% | 2.97B | | +19.98% | 43.48B | | +20.67% | 22.65B | | +14.56% | 14.73B | | +14.32% | 13.79B | | +44.72% | 12.04B | | -8.37% | 7.08B | | -0.05% | 6.79B | | -8.87% | 5.73B | | +11.90% | 5.47B |
Generic Pharmaceuticals
|